Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (88) Arrow Down
Filter Results: (88) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (496)
    • Faculty Publications  (88)

    Show Results For

    • All HBS Web  (496)
      • Faculty Publications  (88)

      Healthcare InnovationRemove Healthcare Innovation →

      ← Page 4 of 88 Results →

      Are you looking for?

      →Search All HBS Web
      • May 2015 (Revised September 2015)
      • Case

      Philips Healthcare: Marketing the HealthSuite Digital Platform

      By: John A. Quelch and Margaret L. Rodriguez
      In June 2014, leading healthcare and consumer technology company, Royal Philips ("Philips"), announced its HealthSuite Digital Platform to house healthcare data and enable applications used by physicians and patients. Philips had strong equity in the healthcare... View Details
      Keywords: Health; Healthcare; Digital; Platform; Ecosystem; Health Care and Treatment; Technological Innovation; Information Technology; Product Development; Applications and Software; Digital Platforms; Health Industry; Medical Devices and Supplies Industry; Netherlands; United States
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Margaret L. Rodriguez. "Philips Healthcare: Marketing the HealthSuite Digital Platform." Harvard Business School Case 515-052, May 2015. (Revised September 2015.)
      • February 2015 (Revised November 2015)
      • Supplement

      Building an Integrated Biopharma Company: Crucell (B)

      By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
      The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
      Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
      • February 2015 (Revised November 2015)
      • Case

      Building an Integrated Biopharma Company: Crucell (A)

      By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
      By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
      Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
      • 2015
      • Other Teaching and Training Material

      Innovating in Healthcare

      By: Regina E. Herzlinger, Margo I. Seltzer and Kevin Schulman
      With over 71,000 past enrollees, Innovating in Healthcare investigates the issues of health care spending, quality, and access that continue to plague America and global nations alike. With U.S. health care costs trending toward $4 trillion in 2020, the need to... View Details
      Keywords: edX; Healthcare; Health Care and Treatment; Innovation and Invention; Business Model
      Citation
      Related
      Herzlinger, Regina E., Margo I. Seltzer, and Kevin Schulman. "Innovating in Healthcare." edX Inc., 2015. Video. (HarvardX Massive Open Online Course.)
      • October 2014 (Revised April 2023)
      • Case

      Gilead: Hepatitis C Access Strategy (A)

      By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
      Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
      Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
      • September 2014
      • Case

      FormPrint Ortho500

      By: Frank V. Cespedes and Alisa Zalosh
      The Senior Vice President of FormPrint's Medical Products business unit is considering issues raised by the upcoming introduction of a new 3D printing system, the Ortho500, which could print custom exoskeletal orthopedic splints, braces, and casts that conformed to a... View Details
      Keywords: B2B Marketing; Technological Innovation; Market Entry and Exit; Marketing Strategy; Distribution Channels; Product Development; Medical Devices and Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Cespedes, Frank V., and Alisa Zalosh. "FormPrint Ortho500." Harvard Business School Brief Case 915-535, September 2014.
      • June 2014 (Revised May 2017)
      • Teaching Note

      Vision 2020: Takeda and the Vaccine Business

      By: John A. Quelch
      Keywords: Asia; Healthcare; Pharmaceuticals; Innovation And Management; Health; Innovation and Invention; Strategy; Leadership; Growth and Development; Change; Health Industry; Pharmaceutical Industry; Asia
      Citation
      Purchase
      Related
      Quelch, John A. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Teaching Note 514-105, June 2014. (Revised May 2017.)
      • May 2014 (Revised March 2016)
      • Case

      Health City Cayman Islands

      By: Tarun Khanna and Budhaditya Gupta
      Narayana Health (NH) had been successfully delivering affordable high quality tertiary care to the masses in India through its chain of hospitals for over a decade. To encourage the adoption of the NH affordable care delivery model worldwide, Dr. Shetty, Chairman of... View Details
      Keywords: Healthcare; Emerging Economies; Innovation; India; Institutions; Pricing; Replication; Strategy; Narayana Health; Ascension; Health City Cayman Islands; Dr. Devi Shetty; International Business; Health Care and Treatment; Innovation Strategy; Innovation and Management; Disruptive Innovation; Cross-Cultural and Cross-Border Issues; Global Strategy; Knowledge Use and Leverage; Management Practices and Processes; Growth Management; Growth and Development Strategy; Market Entry and Exit; Adaptation; Adoption; India; Cayman Islands
      Citation
      Educators
      Purchase
      Related
      Khanna, Tarun, and Budhaditya Gupta. "Health City Cayman Islands." Harvard Business School Case 714-510, May 2014. (Revised March 2016.)
      • April 2014 (Revised January 2015)
      • Background Note

      Note on Mobile Healthcare

      By: John A. Quelch and Margaret L. Rodriguez
      Delivering health care to the global population was a challenge. Health care costs accounted for ten percent of world GDP by 2013. In the U.S., health care costs were expected to top $3.1 trillion in 2014. New technologies, shortages of trained personnel and... View Details
      Keywords: Health Care; Mobile; Mobile App; Public Health; Startups; Hardware; Software; Telemedicine; Global; Medical Devices; Medical Services; Medical Solutions; Entrepreneurs; Government And Business; Technological Change; Health Care and Treatment; Entrepreneurship; Government and Politics; Technological Innovation; Applications and Software; Information Infrastructure; Health Industry; Technology Industry
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Margaret L. Rodriguez. "Note on Mobile Healthcare." Harvard Business School Background Note 514-122, April 2014. (Revised January 2015.)
      • January–February 2014
      • Other Article

      Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them

      By: Regina E. Herzlinger
      Health care in the United States and in most other developed countries is ailing, says Regina E. Herzlinger. A chaired professor of business administration specializing in health care at Harvard Business School, Herzlinger says that although the world has witnessed... View Details
      Keywords: Healthcare; Healthcare IT; Innovation; Health Care and Treatment; Health; Information Technology; Innovation and Invention; Health Industry; Technology Industry; United States
      Citation
      Find at Harvard
      Related
      Herzlinger, Regina E. "Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them." IEEE Pulse 5, no. 1 (January–February 2014): 43–45.
      • November 2013 (Revised June 2014)
      • Case

      E-Cigarettes: Marketing Versus Public Health

      By: John A. Quelch and Margaret L. Rodriguez
      Electronic cigarettes (e-cigarettes) were heralded by some as a healthcare game changer, enabling smokers to switch to a new product which carried lower risk of cancer. However, there were concerns about the public health risk of e-cigarettes, particularly the chance... View Details
      Keywords: Public Health; Tobacco; Smoking; Cigarettes; Electronic Cigarettes; Cancer; Lung; Lorillard; Philip Morris; Safety; Technological Innovation; Conflict of Interests; Market Entry and Exit; Marketing; Health; Advertising; Consumer Products Industry; Health Industry
      Citation
      Educators
      Purchase
      Related
      Quelch, John A., and Margaret L. Rodriguez. "E-Cigarettes: Marketing Versus Public Health." Harvard Business School Case 514-059, November 2013. (Revised June 2014.)
      • May 2013
      • Case

      Kaiser Permanente: Innovating to Transform Healthcare

      By: Lynda Applegate
      This case enables discussion of organizational and industry transformation. View Details
      Keywords: Entrepreneurial Management; Strategy; Organ; Entrepreneurship; Management; Competitive Strategy; Behavior; Leadership; Health Industry; United States
      Citation
      Educators
      Purchase
      Related
      Applegate, Lynda. "Kaiser Permanente: Innovating to Transform Healthcare." Harvard Business School Case 813-184, May 2013.
      • October 2012 (Revised March 2022)
      • Case

      Kleiner-Perkins and Genentech: When Venture Capital Met Science

      By: Felda Hardymon and Tom Nicholas
      Genentech is a rare success story in the biotechnology industry. Hundreds of billions of dollars of venture capital have been invested without the expected transformational effects. Established in 1976, Genentech was to develop the new science of recombinant DNA into... View Details
      Keywords: Innovation & Entrepreneurship; Venture Capital; Innovation and Invention; Entrepreneurship; Information Technology; Science; Biotechnology Industry; United States
      Citation
      Educators
      Purchase
      Related
      Hardymon, Felda, and Tom Nicholas. "Kleiner-Perkins and Genentech: When Venture Capital Met Science." Harvard Business School Case 813-102, October 2012. (Revised March 2022.)
      • August 2012 (Revised August 2014)
      • Case

      Cancer Treatment Centers of America® (A)

      By: Regina E. Herzlinger and Natalie Kindred
      Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who... View Details
      Keywords: Cancer; Cancer Treatment; Health Care; Healthcare; Accountability; Outcomes; Outcomes Measurement; Outcomes Reporting; Hub And Spoke Cancer Care; Hub And Spoke; Hub-and-spoke; Focused Factory; Mission and Purpose; Private Ownership; For-Profit Firms; Health Disorders; Medical Specialties; Policy; Business Model; Expansion; Decision Choices and Conditions; Advertising; Health Care and Treatment; Innovation and Invention; Health Industry; United States
      Citation
      Educators
      Purchase
      Related
      Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
      • November 2011 (Revised August 2012)
      • Case

      Healthymagination at GE Healthcare Systems

      By: Vineet Kumar and V. Kasturi Rangan
      Jeff Immelt, the CEO of GE, introduced a new innovation strategy named "healthymagination" in 2009. With cost, quality, and access as its three pillars, healthymagination ensures a strong focus for new product introduction efforts all around GE. But will this focus... View Details
      Keywords: Innovation and Invention; Product Marketing; Marketing Strategy; Medical Devices and Supplies Industry; Health Industry
      Citation
      Educators
      Purchase
      Related
      Kumar, Vineet, and V. Kasturi Rangan. "Healthymagination at GE Healthcare Systems." Harvard Business School Case 512-039, November 2011. (Revised August 2012.)
      • September 2011 (Revised January 2012)
      • Case

      Telemonitoring at Visiting Nurse Health System

      By: F. Warren McFarlan, Mark Keil and Mala Kaul
      The Telemonitoring at Visiting Nurse Health System case presents one home healthcare organization's efforts to use telemonitoring to improve the quality of care provided to at-risk patients who were discharged from hospitals and needed home care. After two years of... View Details
      Keywords: Capital Budgeting; Cost vs Benefits; Risk Management; Technology Adoption; Technological Innovation; Organizational Change and Adaptation; Competitive Strategy; Health Industry; Technology Industry
      Citation
      Educators
      Purchase
      Related
      McFarlan, F. Warren, Mark Keil, and Mala Kaul. "Telemonitoring at Visiting Nurse Health System." Harvard Business School Case 112-030, September 2011. (Revised January 2012.)
      • March 2010 (Revised April 2014)
      • Case

      American Well: The Doctor Will E-See You Now

      By: Elie Ofek and Ron Laufer
      What is next for healthcare IT provider American Well, whose innovative Online Care technology allows physicians to deliver care to patients online in real time? Using American Well's platform, patients with non-emergency health concerns can communicate with physicians... View Details
      Keywords: Entrepreneurship; Health Care and Treatment; Technological Innovation; Growth and Development Strategy; Market Entry and Exit; Service Delivery; Online Technology; Health Industry
      Citation
      Educators
      Purchase
      Related
      Ofek, Elie, and Ron Laufer. "American Well: The Doctor Will E-See You Now." Harvard Business School Case 510-061, March 2010. (Revised April 2014.)
      • Article

      A Blueprint for Pharmacy Benefits Managers to Increase Value

      By: William Shrank, Michael E. Porter, Sachin H. Jain and Niteesh K. Choudhary
      Pharmacy benefits managers (PBMs) have a unique opportunity to promote public health and generate value in the healthcare system. However, PBMs are largely evaluated on their ability to control costs rather than improve health. PBMs should be evaluated along three... View Details
      Keywords: Opportunities; Health; System; Cost Management; Partners and Partnerships; Motivation and Incentives; Value; Innovation and Invention; Performance Effectiveness; Health Industry; Pharmaceutical Industry
      Citation
      Find at Harvard
      Related
      Shrank, William, Michael E. Porter, Sachin H. Jain, and Niteesh K. Choudhary. "A Blueprint for Pharmacy Benefits Managers to Increase Value." American Journal of Managed Care 15, no. 2 (February 2009).
      • December 2008 (Revised April 2010)
      • Case

      Proteus Biomedical: Making Pigs Fly

      By: Richard G. Hamermesh, Lauren Barley and Ginger Graham
      Proteus is a healthcare start-up that has developed technology to embed electronics for computing and sensing in existing medical devices and drugs. The technology could potentially change the basis of competition in the pharmaceutical industry. The company is... View Details
      Keywords: Business Startups; Entrepreneurship; Technological Innovation; Rights; Negotiation Deal; Business Strategy; Health Industry; Medical Devices and Supplies Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Lauren Barley, and Ginger Graham. "Proteus Biomedical: Making Pigs Fly." Harvard Business School Case 809-051, December 2008. (Revised April 2010.)
      • July–August 2008
      • Article

      Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare

      By: Regina E. Herzlinger
      Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration Chair at the Harvard Business School, Cambridge, MA. She received her bachelor's degree from MIT and her doctorate from the Harvard Business School The first woman to be tenured and... View Details
      Keywords: Consumer-driven Health Care; Health Care and Treatment; Health Industry
      Citation
      Find at Harvard
      Purchase
      Related
      "Interview with a Quality Leader: Regina E. Herzlinger on Consumer-Driven Healthcare." Journal for Healthcare Quality 30, no. 4 (July–August 2008): 17–19.
      • ←
      • 1
      • 2
      • 3
      • 4
      • 5
      • →

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.